Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Окт. 27, 2022
Observations
of
women
and
clinicians
indicated
that
the
prevalence
menstrual
cycle
problems
has
escalated
during
COVID-19
pandemic.
However,
it
was
not
clear
whether
observed
changes
were
related
to
vaccination,
disease
itself
or
pandemic-induced
psychological
alterations.
To
systematically
analyze
this
question,
we
conducted
a
human
online
survey
in
aged
between
18
65
Hungary.
The
1563
individuals
analyzed
our
study
relation
infection,
pandemic
mental
health.
We
found
no
association
vaccine
types
infection
changes.
also
evaluated
alterations
focusing
on
three
parameters
including
length,
menses
length
regularity
phases:
pre-peak,
peak
post-peak
period
Our
finding
did
change
any
periods.
increased,
while
decreased
significantly
when
comparing
pre-
In
addition,
exhibited
both
correlated
with
severity
depression
period,
therefore
concluded
reported
abnormalities
Hungary
might
be
result
elevated
depressive
symptoms.
Human Reproduction Update,
Год журнала:
2022,
Номер
29(2), С. 177 - 196
Опубликована: Ноя. 14, 2022
In
2020,
SARS-CoV-2
and
the
COVID-19
pandemic
had
a
huge
impact
on
access
to
provision
of
ART
treatments.
Gradually,
knowledge
virus
its
transmission
has
become
available,
allowing
activities
resume.
Still,
questions
human
gametes
fertility
remain.
iScience,
Год журнала:
2023,
Номер
26(4), С. 106401 - 106401
Опубликована: Март 15, 2023
There
has
been
increasing
public
concern
that
COVID-19
vaccination
causes
menstrual
disturbance
regarding
the
relative
effect
of
compared
to
SARS-CoV-2
infection.
Our
objectives
were
test
potential
risk
factors
for
reporting
cycle
changes
following
and
compare
parameters
disease.
We
performed
a
secondary
analysis
retrospective
online
survey
conducted
in
UK
March
2021.
In
pre-menopausal
vaccinated
participants
(n
=
4,989),
18%
reported
after
their
first
vaccine
injection.
The
prevalence
any
was
higher
women
who
smoke,
have
history
disease,
or
are
not
using
estradiol-containing
contraceptives.
second
sample
including
both
unvaccinated
12,579),
alone
associated
with
abnormal
parameters,
while
disease
an
increased
heavier
bleeding,
"missed"
periods,
inter-menstrual
bleeding.
npj Digital Medicine,
Год журнала:
2022,
Номер
5(1)
Опубликована: Ноя. 2, 2022
COVID-19
vaccination
may
be
associated
with
change
in
menstrual
cycle
length
following
vaccination.
We
estimated
covariate-adjusted
differences
mean
(MCL),
measured
days,
between
pre-vaccination
cycles,
and
post-vaccination
cycles
within
vaccinated
participants
who
met
eligibility
criteria
the
Apple
Women's
Health
Study,
a
longitudinal
mobile-application-based
cohort
of
people
U.S.
manually
logged
cycles.
A
total
9652
(8486
vaccinated;
1166
unvaccinated)
contributed
128,094
(median
=
10
per
participant;
inter-quartile
range:
4-22).
Fifty-five
percent
received
Pfizer-BioNTech's
mRNA
vaccine,
37%
Moderna's
8%
Johnson
&
Johnson/Janssen
(J&J)
vaccine.
was
small
increase
MCL
for
which
first
dose
(0.50
95%
CI:
0.22,
0.78)
second
(0.39
0.11,
0.67)
vaccines
compared
Cycles
single
J&J
administered
were,
on
average,
1.26
days
longer
(95%
0.45,
2.07)
than
Post-vaccination
returned
to
average
length.
Estimated
follicular
phase
increased
(0.97
0.53,
1.42)
or
(1.43
1.06,
1.80)
(2.27
1.04,
3.50),
Menstrual
appears
temporary
should
not
discourage
individuals
from
becoming
vaccinated.
Climacteric,
Год журнала:
2022,
Номер
25(6), С. 570 - 578
Опубликована: Сен. 30, 2022
Midlife
women
commonly
experience
changes
in
their
cognitive
function
as
they
transition
through
menopause
and
express
concern
about
whether
these
represent
the
initial
stages
of
a
more
serious
disorder.
Health-care
practitioners
play
an
important
role
counseling
on
at
midlife
normalizing
women's
experience.
The
aim
this
commissioned
International
Menopause
Society
White
Paper
cognition
is
to
provide
with
overview
data
informing
clinical
care
menopausal
framework
for
decision-making.
Among
topics
presented
are
specific
occurring
menopause,
duration
such
severity.
estrogen
symptoms
reviewed.
We
present
talking
points
effects
hormone
therapy
dementia
risk
women,
including
discussion
absolute
risk.
Lastly,
brief
review
modifiable
factors
age-related
decline
presented,
guidance
patients
optimizing
brain
health
beyond.
International Journal of Clinical Practice,
Год журнала:
2022,
Номер
2022, С. 1 - 5
Опубликована: Окт. 27, 2022
Several
factors
such
as
stress,
depression,
infection,
and
vaccination
influenced
the
menstrual
cycle
in
women
during
coronavirus
disease
2019
(COVID-19)
pandemic.
We
investigated
whether
there
were
changes
after
COVID-19
or
infection
and,
if
so,
nature
of
change.This
study
was
designed
a
descriptive,
cross-sectional
study.
A
face-to-face
survey
conducted
among
menstruating
aged
18-50
years
from
May
31
to
July
31,
2022.
Women
inquired
about
their
first
three
cycles
that
occurred
vaccination.Of
241
with
86
(35.7%)
mentioned
they
experienced
various
patterns
infection.
Of
537
participants
who
received
vaccines,
82
(15.1%)
stated
vaccination.
The
incidence
postvaccination
change
higher
Pfizer-BioNTech
Sinovac
(CoronaVac)
vaccines.
Only
10.9%
reported
pattern
consulted
physician.COVID-19
can
affect
women.
It
is
important
be
aware
warn
inform
this
issue.
BMJ Sexual & Reproductive Health,
Год журнала:
2024,
Номер
50(3), С. 212 - 225
Опубликована: Июнь 10, 2024
Menstrual
health
is
a
key
patient-reported
outcome
beyond
its
importance
as
general
indicator
of
and
fertility.
However,
menstrual
function
was
not
measured
in
the
clinical
trials
COVID-19
vaccines.
The
purpose
this
review
to
synthesise
existing
literature
on
relationship
between
vaccination
outcomes.
Medicina,
Год журнала:
2024,
Номер
60(2), С. 206 - 206
Опубликована: Янв. 25, 2024
Background
and
Objectives:
Menstrual
changes,
including
altered
cycle
length
bleeding
patterns,
have
been
reported
following
COVID-19
vaccination.
This
study
aimed
to
determine
the
prevalence
types
of
menstrual
changes
occurring
after
vaccination
among
female
students
staff
at
a
university
in
Saudi
Arabia.
Materials
Methods:
A
cross-sectional
was
conducted
women
aged
18–39
years
who
received
least
one
dose
vaccine.
Eligible
participants,
staff,
were
recruited
between
May
2022
November
2022.
Participants
completed
questionnaire
detailing
their
sociodemographic
characteristics,
general
medical
reproductive
history,
characteristics
before
The
various
(cycle
length,
days,
flow,
mid-cycle
spotting)
calculated.
demographic
factors
associated
with
analyzed
using
chi-squared
tests.
Results:
472
included
participants
had
mean
age
20.9
years,
95.3%
unmarried.
Changes
by
54.7%
respondents
overall.
most
common
change
followed
number
menstruation
days
flow.
not
age,
BMI,
occupation,
marital
status,
or
history.
intermenstrual
more
frequently
third
Pfizer
vaccine
compared
Moderna
(p
=
0.014).
Conclusions:
More
than
half
vaccination,
being
common.
potential
underlying
mechanisms
implications
these
alterations
require
further
investigation.
These
findings
provide
evidence
side
effects
vaccines
Molecular Pharmaceutics,
Год журнала:
2024,
Номер
21(2), С. 393 - 409
Опубликована: Янв. 8, 2024
Female
reproductive
health
has
traditionally
been
an
underrepresented
area
of
research
in
the
drug
delivery
sciences.
This
disparity
is
also
seen
emerging
field
mRNA
therapeutics,
a
class
medicines
that
promises
to
treat
and
prevent
disease
by
upregulating
protein
expression
body.
Here,
we
review
advances
therapies
through
lens
improving
female
health.
Specifically,
begin
our
discussing
fundamental
structure
biochemical
modifications
associated
with
mRNA-based
drugs.
Then,
discuss
various
packaging
technologies,
including
lipid
nanoparticles,
can
be
utilized
protect
transport
drugs
target
cells
Last,
conclude
usage
therapy
for
addressing
pregnancy-related
vaccination
against
sexually
transmitted
diseases
women.
Of
note,
highlight
relevant
clinical
trials
using
while
providing
their
corresponding
National
Clinical
Trial
identifiers.
In
undertaking
this
review,
aim
provide
background
understanding
its
specifically
address
issues
overarching
goal
information
toward
gender
certain
aspects
research.
